文献速递消化系统肿瘤

miR-369-3p靶向ACTN4调控肝癌细胞增殖与凋亡的分子机制

[Molecular mechanism of miR-369-3p regulating hepatocellular carcinoma cell proliferation and apoptosis by targeting ACTN4].
PubMed 文献 · Zhonghua Zhong Liu Za Zhi · 2021-01-01

该研究检测肝癌及癌旁组织中miR-369-3p与ACTN4的表达,并在MHCC97H细胞中通过过表达miR-369-3p、抑制ACTN4及回补ACTN4观察增殖、周期与凋亡变化。结果显示miR-369-3p靶向调控ACTN4使细胞周期阻滞于G(1)期,抑制增殖并促进凋亡。

要点

  • 肝癌组织中miR-369-3p表达低于癌旁组织,ACTN4 mRNA和蛋白表达高于癌旁组织。
  • 过表达miR-369-3p或抑制ACTN4均降低MHCC97H细胞增殖、诱导G(1)期阻滞并促进凋亡。
  • 过表达ACTN4可逆转miR-369-3p对MHCC97H细胞增殖、周期和凋亡的作用。

核心结论

  • miR-369-3p可通过靶向调控ACTN4的表达使肝癌细胞周期阻滞于G(1)期,抑制肝癌细胞增殖,促进肝癌细胞凋亡。

研究设计与样本

  • 采用RT-qPCR和Western blot法检测肝癌及癌旁组织中miR-369-3p、ACTN4的表达水平。
  • 采用脂质体法将miR-369-3p mimics、miR-NC、si-ACTN4、si-NC转染至肝癌MHCC97H细胞。
  • 采用MTT法检测细胞增殖,流式细胞仪检测细胞周期和凋亡率,双荧光素酶报告实验验证miR-369-3p对ACTN4的靶向调控作用,Western blot法检测cyclin D1、p21、Bcl-2、Bax的表达。

主要发现

  • 肝癌组织中miR-369-3p表达水平为0.46±0.04,低于癌旁组织的1.00±0.08(P<0.001)。
  • 肝癌组织中ACTN4 mRNA表达水平为3.12±0.29,高于癌旁组织的1.01±0.09(P<0.001);ACTN4蛋白表达水平为0.61±0.06,高于癌旁组织的0.25±0.03(P<0.001)。
  • 与miR-NC组比较,过表达miR-369-3p组细胞培养72 h吸光度为0.71±0.06 vs 1.26±0.11(P<0.001),G(1)期细胞比例为51.56±5.23% vs 31.14±3.36%(P<0.001),S期细胞比例为14.33±1.45% vs 32.44±3.56%(P<0.001),细胞凋亡率为20.16±2.11% vs 6.25±0.64%(P<0.001)。
  • 与si-NC组比较,抑制ACTN4表达组细胞培养72 h吸光度为0.78±0.07 vs 1.24±0.12(P<0.001),G(1)期细胞比例为48.69±4.21% vs 30.33±3.01%(P<0.001),S期细胞比例为18.54±1.61% vs 36.21±3.42%(P<0.001),细胞凋亡率为18.32±1.82% vs 6.58±0.66%(P<0.001)。
  • 与miR-369-3p+pcDNA组比较,过表达ACTN4组细胞培养72 h吸光度为1.12±0.11 vs 0.68±0.06(P<0.001),G(1)期细胞比例为38.81±3.24% vs 51.80±4.57%(P<0.001),S期细胞比例为31.65±3.11% vs 15.69±1.44%(P<0.001),细胞凋亡率为13.86±1.37% vs 22.69±2.24%(P<0.001)。

关键数值与推荐

  • 过表达miR-369-3p后cyclin D1和Bcl-2蛋白相对表达量降低(均P<0.001),p21和Bax蛋白相对表达量升高(均P<0.001)。
  • 抑制ACTN4表达后cyclin D1和Bcl-2蛋白水平降低(均P<0.001),p21和Bax蛋白水平升高(均P<0.001)。
  • 过表达ACTN4后cyclin D1和Bcl-2蛋白相对表达量升高(均P<0.001),p21和Bax蛋白相对表达量降低(均P<0.001)。

临床怎么用

  • 原文未据此给出临床推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Objective: To investigate the effect of miR-369-3p targeting ACTN4 expression on proliferation and apoptosis of hepatocellular carcinoma cells. Methods: Real-time quantitative polymerase chain reaction (RT-qPCR) and western blot were used to detect the expression levels of miR-369-3p and ACTN4 in hepatocarcinoma tissues and adjacent tissues. MiR-369-3p mimics, miR-negative control (NC), si-ACTN4, and si-NC were transfected into hepatocellular carcinoma MHCC97H cells by liposome method. Cell proliferation was detected by 3-(4, 5-Dimethylthiazol-2-yl)-2, 5-dipheny-ltetrazolium bromide (MTT) assay. Flow cytometry was used to detect cell cycle and apoptotic rates. The dual luciferase reporter assay was used to verify the targeted regulation of ACTN4 by miR-369-3p. Western blot was used to detect the expressions of cyclin D1, p21, Bcl-2 and Bax. Results: The expression level of miR-369-3p in liver cancer tissue was lower than that in adjacent tissues [(0.46±0.04) vs (1.00±0.08), P<0.001)], while the expression level of ACTN4 was higher than that in adjacent tissues [mRNA (3.12±0.29) vs (1.01±0.09); protein (0.61±0.06) vs (0.25±0.03), P<0.001]. Overexpression of miR-369-3p significantly decreased the cell viability[(0.71±0.06) vs (1.26±0.11), P<0.001)], increased cell apoptosis rate [(20.16±2.11)% vs (6.25±0.64)%, P<0.001], increased the proportion of cells in G(1) phase [(31.14±3.36)% vs (51.56±5.23)%, P<0.001], decreased the proportion of cells in S phase [(32.44±3.56)% vs (14.33) ±1.45)%, P<0.001], increased the levels of p21 and Bax protein (P<0.001), and decreased the levels of cyclin D1 and Bcl-2 protein (P<0.001). Inhibition of the expression of ACTN4 significantly reduced the cell viability [(0.78±0.07) vs (1.24±0.12), P<0.001], increased the apoptosis rate [(6.58±0.66)% vs (18.32±1.82)%, P<0.001], increased the proportion of cells in G(1) phase [(48.69±4.21)% vs (30.33±3.01)%, P<0.001], decreased the proportion of cells in S phase [(36.21±3.42)% vs (18.54±1.61)%, P<0.001], increased the protein levels of p21 and Bax (P<0.001), and decreased the levels of cyclin D1 and Bcl-2 protein (P<0.001). Compared with the miR-369-3p+ pcDNA group, overexpression of ACTN4 increased the proliferation ability of hepatocellular carcinoma MHCC97H cells at 72 hours of culture[(1.12±0.11) vs (0.68±0.06), P<0.001], significantly reduced the proportion of cells in G(1) stage [(38.81±3.24)% vs (51.80±4.57)%, P<0.001], significantly increased the proportion of S-phase cells [(31.65±3.11)% vs (15.69±1.44)%, P<0.001], decreased cell apoptosis rate [(13.86±1.37)% vs (22.69±2.24)%, P<0.001], increased protein expressions of cyclin D1 and Bcl-2 (P<0.001), decreased the protein expressions of p21 and Bax (P<0.001). Conclusion: MiR-369-3p can induce cell cycle arrest in G(1) phase, inhibit the proliferation and promote apoptosis of liver cancer cells by regulating the expression of ACTN4. 目的: 探讨微小RNA miR-369-3p靶向调控α-辅肌动蛋白4(ACTN4)表达对肝癌细胞增殖和凋亡的影响。 方法: 采用实时荧光定量聚合酶链反应(RT-qPCR)和Western blot法分别检测肝癌及癌旁组织中miR-369-3p、ACTN4的表达水平。采用脂质体法将miR-369-3p mimics、miR-NC、si-ACTN4、si-NC转染至肝癌MHCC97H细胞。采用四甲基偶氮唑蓝(MTT)法检测细胞增殖,流式细胞仪检测细胞周期和凋亡率,双荧光素酶报告实验验证miR-369-3p对ACTN4的靶向调控作用,Western blot法检测细胞周期蛋白1(cyclin D1)、p21、B淋巴细胞瘤2 (Bcl-2)、Bcl-2相关蛋白(Bax)的表达。 结果: 肝癌组织中miR-369-3p mRNA的表达水平为0.46±0.04,低于癌旁组织(1.00±0.08, P<0.001);ACTN4 mRNA的表达水平为3.12±0.29,高于癌旁组织(1.01±0.09, P<0.001);ACTN4蛋白的表达水平为0.61±0.06,高于癌旁组织(0.25±0.03,P<0.001)。与miR-NC组细胞比较,miR-369-3p过表达肝癌MHCC97H细胞增殖能力降低(细胞培养72 h吸光度分别为0.71±0.06和1.26±0.11,P<0.001),G(1)期细胞比例升高[分别为(51.56±5.23)%和(31.14±3.36)%,P<0.001],S期细胞比例降低[分别为(14.33±1.45)%和(32.44±3.56)%,P<0.001)],细胞凋亡率升高[分别为(20.16±2.11)%和(6.25±0.64)% , P<0.001],cyclin D1和Bcl-2蛋白相对表达量降低(均P<0.001),p21和Bax蛋白相对表达量升高(均P<0.001)。与si-NC组比较,抑制ACTN4的表达后,肝癌MHCC97H细胞增殖能力降低(细胞培养72 h吸光度分别为0.78±0.07和1.24±0.12,P<0.001),G(1)期细胞比例升高[分别为(48.69±4.21)%和(30.33±3.01)%,P<0.001],S期细胞比例降低[(分别为18.54±1.61)%和(36.21±3.42)%,P<0.001],细胞凋亡率升高[分别为(18.32±1.82)%和(6.58±0.66)%,P<0.001],cyclin D1和Bcl-2蛋白水平降低(均P<0.001),p21和Bax蛋白水平升高(均P<0.001)。与miR-369-3p+pcDNA组比较,过表达ACTN4后,肝癌MHCC97H细胞增殖能力提高(细胞培养72 h吸光度分别为1.12±0.11和0.68±0.06,P<0.001),G(1)期细胞比例显著降低[(38.81±3.24)%和(51.80±4.57)%,P<0.001],S期细胞比例显著升高[(31.65±3.11)%和(15.69±1.44)%,P<0.001],细胞凋亡率降低[分别为(13.86±1.37)%和(22.69±2.24)%, P<0.001],cyclin D1和Bcl-2蛋白相对表达量升高(均P<0.001),p21和Bax蛋白相对表达量降低(均P<0.001)。 结论: miR-369-3p可通过靶向调控ACTN4的表达使肝癌细胞周期阻滞于G(1)期,抑制肝癌细胞增殖,促进肝癌细胞凋亡。.

来源:Zhonghua Zhong Liu Za Zhi,查看原文。版权归原作者所有。

引用

  1. Zhao HF, Lou M, Bi MP, et al. [Molecular mechanism of miR-369-3p regulating hepatocellular carcinoma cell proliferation and apoptosis by targeting ACTN4]. Zhonghua Zhong Liu Za Zhi. 2021. PMID: 34794217. doi:10.3760/cma.j.cn112152-20191107-00719

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。